GleamWall
中文EN

ABSI Absci Corp

Services-Commercial Physical & Biological Research · Nasdaq · SEC CIK 1672688 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-47.2%
TTM net income YoY-9.7%
TTM EPS YoY13.2%
Revenue 3-yr CAGR-40.2%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-8,812.3%
Net margin-8,451.3%
FCF margin-7,562.7%
EBITDA margin-8,076.6%

Returns

ROE-58.6%
ROA-51.9%
ROIC (approx.)-53.3%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets8.7%
Debt / equity0.00x
Current ratio9.64x
Interest coverage-2,569.39x

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-5.4%
Payout ratio—
Capex / revenue-4.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.80M$4.53M
R&D expense$81.42M$63.86M
SG&A expense$35.06M$36.17M
Operating income-$120.32M-$108.89M
Interest expense$209,000$565,000
Pretax income-$115.11M-$103.04M
Income tax$69,000$70,000
Net income-$115.18M-$103.11M
EBITDA-$108.58M-$95.50M
EPS (basic)-0.84-0.94
EPS (diluted)-0.84-0.94
Weighted avg. shares (diluted)136.78M110.24M
Balance sheet
Cash & equivalents$20.02M$58.21M
Short-term investments$124.27M$71.21M
Receivables—$0
Current assets$149.57M$133.83M
PP&E, net$20.86M$29.17M
Intangibles$41.51M$44.88M
Total assets$216.30M$213.61M
Current liabilities$22.77M$28.66M
Long-term debt—$3.99M
Total debt—$3.99M
Total liabilities$26.85M$34.48M
Shareholders' equity$189.45M$179.13M
Net debt—-$54.22M
Shares outstanding—115.36M
Cash flow statement
Operating cash flow-$92.92M-$72.40M
Capital expenditure$1.11M$404,000
Free cash flow-$94.03M-$72.81M
Investing cash flow-$50.16M-$41.58M
Financing cash flow$105.95M$82.53M
Depreciation & amortization$11.74M$13.39M
Stock-based compensation$18.32M$19.45M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.